Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.
|
1 |
Bailey-Wilson J et al. |
Analysis of Xq27-28 linkage in the international consortium for prostate cancer genetics (ICPCG) families.
|
|
2 |
Behre H et al. |
A randomized, double-blind, placebo-controlled trial of testosterone gel on body composition and health-related quality-of-life in men with hypogonadal to low-normal levels of serum testosterone and symptoms etc.
|
|
3 |
Chapple CHR et al. |
[Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in Europe].
|
|
4 |
Choudhury A et al. |
The role of genetic markers in the management of prostate cancer.
|
|
5 |
Damber JE et al. |
The effect of baseline testosterone on the efficacy of degarelix and leuprolide: further insights from a 12-month, comparative, phase III study in prostate cancer patients.
|
|
6 |
Egardie RB et al. |
Responder analysis of the effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancer.
|
|
7 |
Hakala T et al. |
Rising incidence of small size papillary thyroid cancers with no change in disease-specific survival in finnish thyroid cancer patients.
|
|
8 |
Heervä E et al. |
A controlled register-based study of 460 neurofibromatosis 1 patients: Increased fracture risk in children and adults over 41 years of age.
|
|
9 |
Heijnsdijk E et al. |
Quality-of-life effects of prostate-specific antigen screening.
|
|
10 |
Hernesniemi JA et al. |
Genetic profiling using genome-wide significant coronary artery disease risk variants does not improve the prediction of subclinical atherosclerosis: the Cardiovascular Risk in Young Finns Study, the Bogalusa Heart Study and the Health 2000
Survey--...
|
|
11 |
Huuskonen A et al. |
Aerobic Fitness Does Not Modify the Effect of FTO Variation on Body Composition Traits.
|
|
12 |
Inouye M et al. |
Novel Loci for metabolic networks and multi-tissue expression studies reveal genes for atherosclerosis.
|
|
13 |
Jalava SE et al. |
Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer.
|
|
14 |
Jin G et al. |
Validation of prostate cancer risk-related loci identified from genome-wide association studies using family-based association analysis: evidence from the International Consortium for Prostate Cancer Genetics (ICPCG).
|
|
15 |
Juuti H et al. |
The Effect of pH on the Degradation of Biodegradable Poly(L-Lactide-Co-Glycolide) 80/20 Urethral Stent Material In Vitro.
|
|
16 |
Kaipia A, Petas A. |
Robottikirurgia yleistyy urologiassa.
|
|
17 |
Kauppi JT et al. |
Locally advanced esophageal adenocarcinoma: response to neoadjuvant chemotherapy and survival predicted by ([18F])FDG-PET/CT.
|
|
18 |
Kotsar A et al. |
Preclinical evaluation of new indomethacin-eluting biodegradable urethral stent.
|
|
19 |
Lehmusvaara S et al. |
Chemical castration and anti-androgens induce differential gene expression in prostate cancer.
|
|
20 |
Levula M et al. |
Genes involved in systemic and arterial bed dependent atherosclerosis - tampere vascular study.
|
|
21 |
Lu L et al. |
Chromosomes 4 and 8 implicated in a genome wide SNP linkage scan of 762 prostate cancer families collected by the ICPCG.
|
|
22 |
Melkas S et al. |
Post-stroke delirium in relation to dementia and long-term mortality.
|
|
23 |
Melkas S et al. |
Extensive white matter changes predict stroke recurrence up to 5 years after a first-ever ischemic stroke.
|
|
24 |
Mennander A et al. |
Diazoxide may protect endothelial glycocalyx integrity during coronary artery bypass grafting.
|
|
25 |
Murtola T et al. |
The importance of LDL and cholesterol metabolism for prostate epithelial cell growth.
|
|
26 |
Ojala-Oksala J et al. |
Educational history is an independent predictor of cognitive deficits and long-term survival in postacute patients with mild to moderate ischemic stroke.
|
|
27 |
Pakkanen S et al. |
Clinical and histopathological characteristics of familial prostate cancer in Finland.
|
|
28 |
Pöyhönen A et al. |
Prevalence and bother of postmicturition dribble in Finnish men aged 30-80 years: Tampere Ageing Male Urologic Study (TAMUS).
|
|
29 |
Pöyhönen A et al. |
Prevalence of hesitancy in 30-80-year-old Finnish men: Tampere Ageing Male Urological Study (TAMUS).
|
|
30 |
Roine A et al. |
Detection of smell print differences between nonmalignant and malignant prostate cells with an electronic nose.
|
|
31 |
Sallisalmi M et al. |
Evaluation of sublingual microcirculatory blood flow in the critically ill.
|
|
32 |
Sallisalmi M et al. |
Vascular adhesion protein-1 and syndecan-1 in septic shock.
|
|
33 |
Salonen A et al. |
The FinnProstate Study VII: Intermittent Versus Continuous Androgen Deprivation in Patients With Advanced Prostate Cancer.
|
|
34 |
Schröder F et al. |
Screening for Prostate Cancer Decreases the Risk of Developing Metastatic Disease: Findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC).
|
|
35 |
Schröder F et al. |
Prostate-cancer mortality at 11 years of follow-up.
|
|
36 |
Smith M et al. |
Sarcopenia during androgen-deprivation therapy for prostate cancer.
|
|
37 |
Smith M et al. |
Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial.
|
|
38 |
Tammela T et al. |
Eturauhasen hyvänlaatuinen liikakasvu.
|
|
39 |
Tammela TL. |
Endocrine prevention and treatment of prostate cancer.
|
|
40 |
Urbanucci A et al. |
Overexpression of androgen receptor enhances the binding of the receptor to the chromatin in prostate cancer.
|
|
41 |
Urbanucci A et al. |
Overexpression of androgen receptor enhances the binding of the receptor to the chromatin in prostate cancer.
|
|
42 |
Vakhitov D et al. |
Challenging treatment of multiple late complications after endovascular aneurysm repair.
|
|
43 |
Väärämäki S et al. |
Long-term experience of endovascular aneurysm repair with Zenith prosthesis: diminishing graft-related complications over time.
|
|
44 |
Wu GH et al. |
Number of screens for overdetection as an indicator of absolute risk of overdiagnosis in prostate cancer screening.
|
|
45 |
Wu GH et al. |
The impact of interscreening interval and age on prostate cancer screening with prostate-specific antigen.
|
|
46 |
Yang R et al. |
High mobility group B1 impairs hepatocyte regeneration in acetaminophen hepatotoxicity.
|